Fred B. Craves, Director at PONIARD PHARMACEUTICALS, INC. (PARD), bought 25,000 shares at $1.72 ($44K) on 2008-12-19, disclosed to the SEC on 2008-12-23.
Open-market purchase of $44k PARD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.66 | 200 | $332 | 0.8% |
| 2 | $1.67 | 500 | $835 | 1.9% |
| 3 | $1.68 | 200 | $336 | 0.8% |
| 4 | $1.69 | 1,500 | $3K | 5.8% |
| 5 | $1.70 | 400 | $680 | 1.6% |
| 6 | $1.71 | 200 |
| $342 |
| 0.8% |
| 7 | $1.72 | 2,500 | $4K | 9.8% |
| 8 | $1.73 | 1,700 | $3K | 6.7% |
| 9 | $1.74 | 5,400 | $9K | 21.5% |
| 10 | $1.75 | 3,800 | $7K | 15.2% |
| 11 | $1.76 | 500 | $880 | 2.0% |
| 12 | $1.77 | 1,500 | $3K | 6.1% |
| 13 | $1.78 | 900 | $2K | 3.7% |
| 14 | $1.79 | 1,400 | $3K | 5.7% |
| 15 | $1.80 | 2,400 | $4K | 9.9% |
| 16 | $1.81 | 900 | $2K | 3.7% |
| 17 | $1.82 | 200 | $364 | 0.8% |
| 18 | $1.84 | 300 | $552 | 1.3% |
| 19 | $1.86 | 500 | $930 | 2.1% |
| Total | $1.75 avg | 25,000 | $44K | 100% |
| Filing → |
| MDGL | SELL | 2024-11-27 | $1.2M | — | Filing → |
| MDGL | SELL | 2024-05-16 | $9.3M | — | Filing → |
| MDGL | SELL | 2020-08-19 | $5.2M | — | Filing → |